LAVIOLA, Luigi
 Distribuzione geografica
Continente #
NA - Nord America 17.075
AS - Asia 6.000
EU - Europa 5.237
SA - Sud America 1.572
Continente sconosciuto - Info sul continente non disponibili 542
AF - Africa 263
OC - Oceania 13
Totale 30.702
Nazione #
US - Stati Uniti d'America 16.589
SG - Singapore 2.449
IT - Italia 1.919
CN - Cina 1.460
BR - Brasile 1.231
SE - Svezia 674
HK - Hong Kong 644
RU - Federazione Russa 536
DE - Germania 420
VN - Vietnam 392
FR - Francia 351
FI - Finlandia 346
GB - Regno Unito 310
UA - Ucraina 295
IN - India 227
CA - Canada 217
BD - Bangladesh 190
AR - Argentina 115
ID - Indonesia 89
IQ - Iraq 82
NL - Olanda 75
MX - Messico 73
CI - Costa d'Avorio 68
TR - Turchia 58
EC - Ecuador 57
PK - Pakistan 57
JP - Giappone 56
BE - Belgio 51
CO - Colombia 51
ZA - Sudafrica 46
ES - Italia 43
PL - Polonia 42
VE - Venezuela 41
SA - Arabia Saudita 39
IE - Irlanda 37
CR - Costa Rica 36
UZ - Uzbekistan 34
MY - Malesia 33
AT - Austria 30
MA - Marocco 30
PH - Filippine 28
JM - Giamaica 27
CL - Cile 25
PE - Perù 24
GT - Guatemala 23
EG - Egitto 22
LT - Lituania 21
TN - Tunisia 21
HN - Honduras 20
IL - Israele 20
JO - Giordania 20
NI - Nicaragua 17
KE - Kenya 16
TT - Trinidad e Tobago 15
CZ - Repubblica Ceca 13
PR - Porto Rico 13
PY - Paraguay 13
AE - Emirati Arabi Uniti 12
SV - El Salvador 12
AU - Australia 11
DZ - Algeria 11
GR - Grecia 11
NP - Nepal 11
AZ - Azerbaigian 10
CW - ???statistics.table.value.countryCode.CW??? 10
KG - Kirghizistan 10
KZ - Kazakistan 10
PA - Panama 10
SC - Seychelles 9
KR - Corea 8
LB - Libano 8
OM - Oman 8
AL - Albania 7
BO - Bolivia 7
CH - Svizzera 7
BY - Bielorussia 6
ET - Etiopia 6
GP - Guadalupe 6
IR - Iran 6
SY - Repubblica araba siriana 6
AM - Armenia 5
BB - Barbados 5
EE - Estonia 5
HR - Croazia 5
HU - Ungheria 5
LY - Libia 5
NG - Nigeria 5
PS - Palestinian Territory 5
PT - Portogallo 5
SN - Senegal 5
DO - Repubblica Dominicana 4
GY - Guiana 4
RO - Romania 4
TH - Thailandia 4
TW - Taiwan 4
DK - Danimarca 3
GE - Georgia 3
GH - Ghana 3
QA - Qatar 3
RS - Serbia 3
Totale 30.118
Città #
Ashburn 2.381
Singapore 1.346
Fairfield 1.222
San Jose 1.138
Chandler 978
Woodbridge 974
Houston 698
Jacksonville 675
Hong Kong 637
Nyköping 527
Cambridge 495
Milan 490
Ann Arbor 474
Seattle 473
Beijing 396
Wilmington 364
Dearborn 343
Council Bluffs 320
New York 310
Los Angeles 258
Bari 236
Roxbury 214
Lauterbourg 211
Lawrence 204
Rome 203
Nanjing 202
Dallas 177
Helsinki 172
Boardman 167
São Paulo 146
Des Moines 142
Santa Clara 140
Ho Chi Minh City 128
Inglewood 96
Brooklyn 92
Buffalo 86
Columbus 85
Princeton 82
Hanoi 79
Munich 76
London 72
San Diego 71
Abidjan 68
Orem 57
Hebei 55
Chicago 52
Montreal 52
Nanchang 51
Rio de Janeiro 51
Jiaxing 50
Shenyang 50
Toronto 50
San Francisco 49
Brussels 48
Falkenstein 47
Moscow 45
Phoenix 45
Atlanta 44
Frankfurt am Main 44
Jakarta 44
Tokyo 44
Hefei 43
Paris 38
Baghdad 37
Chennai 37
Belo Horizonte 36
Denver 35
Tianjin 35
Naples 34
Turin 34
Guangzhou 33
Amsterdam 32
Dublin 32
Pune 32
San José 31
Warsaw 31
Kunming 30
Nuremberg 29
Tashkent 29
Jinan 27
Redwood City 27
Boston 25
Figino 25
Changsha 24
Manchester 23
Turku 23
Washington 22
Bologna 21
Curitiba 21
Johannesburg 21
Brasília 20
Dong Ket 20
Guatemala City 20
Mexico City 20
Porto Alegre 20
Foggia 19
Haiphong 19
Poplar 19
Shanghai 19
Barnet 18
Totale 19.587
Nome #
Effects of CPAP on testosterone levels in patients with obstructive sleep apnea: a meta-analysis study 680
Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy 296
Reduced SIRT1 and SIRT2 expression promotes adipogenesis of human visceral adipose stem cells and associates with accumulation of visceral fat in human obesity 270
Long-term exposure of pancreatic β-cells to palmitate results in SREBP-1C-dependent decreases in GLP-1 receptor signaling via CREB and AKT and insulin secretory response 252
Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis 243
Abnormalities of insulin-like growth factor-l Signaling and Impaired Cell Proliferation in Osteoblasts from Subjects with Osteoporosis 235
Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea 235
Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases 230
Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy 226
GLP-1: a new approach for type 2 diabetes therapy 224
PKB/Akt and MAPK/ERK phosphorylation is highly induced by inositols: Novel potential insights in endothelial dysfunction in preeclampsia 219
Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy 219
The p66Shc Protein Controls Redox Signaling and Oxidation-Dependent DNA Damage in Human Liver Cells 211
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 209
Diabetes and cancer: pathophysiological fundamentals of a 'dangerous affair' 206
Insulin and Insulin Receptors in Adipose Tissue Development 201
Deregulation of autophagy under hyperglycemic conditions is dependent on increased lysin63 ubiquitination: a candidate mechanism in the progression of diabetic nephropathy 199
GLP-1 Receptor Agonist Added to Insulin versus Basal-plus or Basal-bolus Insulin Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis 198
Irisin Increases the Expression of Anorexigenic and Neurotrophic Genes in Mouse Brain 191
GLP-1 Receptor Activation Inhibits Palmitate-Induced Apoptosis via Ceramide in Human Cardiac Progenitor Cells 188
Clinical view on the need to develop new anti-diabetic drugs 187
The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells 187
Adipose tissue precursor cells 185
Interventional therapy in diabetic foot: Risk factors, clinical events and prognosis at one year follow-up (a study of 103 cases) 182
Effects of irisin on leptin and ghrelin secretion and expression of the major appetite regulators in mouse brain 179
Irisin improves the secretory defects of pancreatic islets from type 2 diabetic subjects 177
The myokine irisin is released in response to saturated fatty acids and promotes pancreatic β-cell survival and insulin secretion 176
Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway. 176
Relationship between risk factors and mortality in type 1 diabetic patients in europe: The eurodiab prospective complications study (PCS) 176
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 175
Irisin Enhances Pancreatic Beta-Cell Survival and Insulin Secretion and Can Mediate the Metabolic Cross Talk between the Skeletal Muscle and Endocrine Pancreas 175
Comparison of Distinct GLP-1 Receptor Agonists in Palmitate-induced Incretin Resistance of Pancreatic Beta Cells 175
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 174
Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta-Analysis 173
Association between physical activity estimated by the International physical activity questionnaire and UKPDS cardiovascular risk in score type 2 diabetes. 173
Effects of Extra Virgin Olive Oil Polyphenols on Pancreatic Beta-Cell Function and Survival 172
Abnormalities of cardiac insulin signaling in experimental diabetes 171
The p66Shc protein mediates saturated fatty acid-induced insulin resistance in pancreatic beta cells 171
Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies 171
Apoptotic and survival signals triggered by high glucose in human mesangial cells. 170
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. 170
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study 168
The SUMO-conjugating enzyme Ubc9 is essential for insulin-responsive glucose transport in adipocytes. 167
Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane 165
Ubc9 regulation of glucose transport in 3T3-L1 adipocytes is differentiation-dependent. 164
Chronic palmitate excess results in reduced exendin-4 action and signalling via CREB and Akt in pancreatic beta cells 164
The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method 161
Effects of extra virgin olive oil polyphenols on beta-cell function and survival 161
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial. 160
Dysmetabolic adipose tissue in obesity: morphological and functional characteristics of adipose stem cells and mature adipocytes in healthy and unhealthy obese subjects 159
Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis 159
Commentary: Glucose control: Not just a bystander in GLP-1RA-mediated cardiovascular protection 155
Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials. 154
Functional loss of pancreatic islets in type 2 diabetes: How can we halt it? 154
Carriers of the TCF7L2 rs7903146 variant with GMD have an increate risk of developing impaired glucose regulation after pregnancy. 153
Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy 153
Decreased IRS phosphorylation and altered Erk activation in osteoblasts from osteoporotic subjects. 152
The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment. 152
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: A cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study 152
Biological specificity of visceral adipose tissue and therapeutic intervention 151
Abnormalities in IGF-I signalling and impaired cell proliferation in osteoblasts from patients with osteoporosis. 150
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 150
HbA1c Variability as an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study. 148
Glucagon-Like Peptide-1 Counteracts Oxidative Stress-Dependent Apoptosis of Human Cardiac Progenitor Cells by Inhibiting the Activation of the c-Jun N-terminal Protein Kinase Signaling Pathway 147
The myokine irisin is released in response to saturated fatty acids and enhances pancreatic beta cell survival and insulin secretion 147
Correction of Intermittent Hypoxia with CPAP Improves Cardiometabolic Abnormalities, and Systemic and Adipose Tissue Inflammation in Obese Subjects with Obstructive Sleep Apnea. 146
Differences in gene expression and cytokine release profiles highlight the heterogeneity of distinct subsets of adipose tissue-derived stem cells in the subcutaneous and visceral adipose tissue in humans. 146
A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial 145
The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis 144
TNFα Signals via p66(Shc) to Induce E-Selectin, Promote Leukocyte Transmigration and Enhance Permeability in Human Endothelial Cells 144
The p66Shc Protein Mediates Insulin Resistance and Secretory Dysfunction in Pancreatic β-Cells Under Lipotoxic Conditions 143
Associated hormonal declines in aging: DHEAS 142
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. 142
Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study. 141
Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling 141
Cross-Talk between PPARgamma and Insulin Signaling and Modulation of Insulin Sensitivity 140
Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia. 140
Exploiting the pleiotropic actions of GLP-1 for the management of type 2 diabetes mellitus and its complications. 139
Specific metabolic effects of insulin detemir in human visceral adipocytes differentiated in vitro from precursor stromal cells. 139
Different gene expression in human heart tissue and progenitor cells from control and diabetic subjects: relevance to the pathogenesis of human diabetic cardiomyopathy 139
TNF alpha impairs insulin signaling in pancreatic beta-cells through JNK-dependent serine phosphorylation of IRS-2. 139
The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor 139
58th EASD Annual Meeting of the European Association for the Study of Diabetes : Stockholm, Sweden, 19 - 23 September 2022 138
Involvement of actin cytoskeleton in free fatty acid-induced beta cell death 138
Impact of Dysfunctional Adipose Tissue Depots on the Cardiovascular System 137
Involvement of the p66Shc protein in glucose transport regulation in skeletal muscle myoblasts 137
Direct evidence for interaction of Gi-protein a subunits and the cytoplasmic domain of the insulin receptor using the yeast two-hybrid system. 135
Pathophysiology of type 2 diabetes: rationale for different oral antidiabetic treatment strategies 135
P2 purinergic agonists and 12-O-tetradecanoylphorbol-13-acetate, as well as protein kinase A activators, stimulate thyroglobulin secretion in FRTL-5 cells 135
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 135
The p66Shc isoform controls the actin cytoskeleton and the glucose transport system in skeletal muscle cells. 134
Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo 133
Prolonged exposure of pancreatic beta-cells to palmitate results in reduced incretin action and signaling via CREB and Akt. 133
Genetic mutation of p66Shc protein at Ser36 prevents oxidative stress human liver cells. 133
Key role of the p66Shc protein in the regulation of the glucose transport system in skeletal muscle cells. 131
Evaluation of a digital tool supporting therapeutic decision making for the personalized management of patients with type 2 diabetes not treated with insulin: A pilot study 129
PPAR-gamma agonisti nella terapia del diabete mellito e di altre malattie endocrino-metaboliche 128
Involvement of Actin Cytoskeleton in Free Fatty Acid-induced Beta-Cell Death. 128
Role of the SUMO-conjugating enzyme Ubc9 in adipocyte differentiation 127
Role of p66Shc in cytokine-mediated leukocyte recruitment by endothelial cells. 127
Totale 17.175
Categoria #
all - tutte 120.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.193 0 0 0 0 62 86 56 88 108 98 280 415
2022/20232.588 326 293 147 233 318 396 34 287 445 17 55 37
2023/2024935 77 184 54 72 111 236 14 53 14 32 4 84
2024/20253.868 58 67 307 134 117 377 354 401 203 187 572 1.091
2025/20269.492 1.261 437 490 1.063 1.077 569 1.064 281 959 999 329 963
2026/20274.130 662 662 1.111 1.671 24 0 0 0 0 0 0 0
Totale 30.702